Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:23 pm Purchase | 2024-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 6,982,425 6.900% | 756,032 (+12.14%) | Filing History |
| 2024-11-14 3:06 pm Purchase | 2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 6,226,393 6.600% | 325,050 (+5.51%) | Filing History |
| 2024-11-12 1:20 pm Unchanged | 2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | VANGUARD GROUP INC | 7,785,909 8.230% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:16 am Purchase | 2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | VANGUARD GROUP INC | 7,785,909 8.230% | 7,785,909 (New Position) | Filing History |
| 2024-02-14 07:00 am Sale | 2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Point72 Asset Management, L.P. | 2,552,822 3.200% | -1,508,521 (-37.14%) | Filing History |
| 2024-02-13 5:08 pm Purchase | 2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | SUVRETTA CAPITAL MANAGEMENT LLC | 4,572,836 5.700% | 723,898 (+18.81%) | Filing History |
| 2024-02-13 12:47 pm Purchase | 2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 5,901,343 7.400% | 1,338,832 (+29.34%) | Filing History |
| 2024-02-06 09:36 am Purchase | 2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | BlackRock Inc. BLK | 5,762,738 7.200% | 1,606,592 (+38.66%) | Filing |
| 2024-01-23 10:47 am Sale | 2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | STATE STREET CORP STT | 3,870,839 4.820% | -720,223 (-15.69%) | Filing History |
| 2023-10-18 4:15 pm Purchase | 2023-10-17 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Point72 Asset Management, L.P. | 4,061,343 5.100% | 4,061,343 (New Position) | Filing History |
| 2023-02-13 1:31 pm Purchase | 2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | SUVRETTA CAPITAL MANAGEMENT LLC | 3,848,938 5.700% | 8,600 (+0.22%) | Filing History |
| 2023-02-13 12:49 pm Purchase | 2022-12-31 | 13G | Farmers & Merchants Bancorp, Inc. FMAO | BlackRock Inc. BLK | 4,156,146 6.100% | 4,156,146 (New Position) | Filing History |
| 2023-02-13 10:14 am Purchase | 2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 4,562,511 6.700% | 4,562,511 (New Position) | Filing History |
| 2023-02-08 10:16 am Purchase | 2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | STATE STREET CORP STT | 4,591,062 6.740% | 4,591,062 (New Position) | Filing History |
| 2022-11-02 09:35 am Purchase | 2022-10-21 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | SUVRETTA CAPITAL MANAGEMENT LLC | 3,840,338 5.600% | 3,840,338 (New Position) | Filing History |